Enrollment in AZURE-1, a global pivotal clinical trial evaluating the efficacy and safety of brelovitug compared to delayed treatment, continues on track REDWOOD CITY, Calif., Sept. 04, 2025 (GLOBE ...
First patient enrolled in AZURE-2 study comparing brelovitug to Hepcludex Bluejay Therapeutics has enrolled the first patient in AZURE-2, a global phase 3 clinical trial evaluating brelovitug (BJT-778 ...
ANN ARBOR, Mich.--(BUSINESS WIRE)--Online Tech is pleased to announce that for a limited time, its managed Microsoft Azure offering with SprawlGuard™ protection is available for a free 30-day trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback